{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T01:35:35Z","timestamp":1749951335516},"reference-count":40,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,1,2]]},"DOI":"10.1080\/14740338.2023.2203482","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T05:49:19Z","timestamp":1681796959000},"page":"137-144","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Association between methotrexate-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis and furosemide: a real-world disproportionality analysis"],"prefix":"10.1080","volume":"23","author":[{"given":"Shengnan","family":"Zhuo","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu","family":"Dong","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongsheng","family":"Yue","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Qian","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinling","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31821201ed"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.09.029"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.002"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.072"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2019.0977"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0158-0"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200220666190130161758"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1777"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13354"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex286"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152909"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2016.05.004"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab347"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.668"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1742"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04037.x"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1695"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050466"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.811570"},{"issue":"7","key":"e_1_3_6_22_1","first-page":"589","article-title":"Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at the University Hospital of the West Indies, Jamaica","volume":"62","author":"East-Innis AD","year":"2013","unstructured":"East-Innis AD, Thompson DS. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at the University Hospital of the West Indies, Jamaica. W Indian Med J. 2013 Sep;62(7):589\u2013592.","journal-title":"W Indian Med J"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2004.06.012"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_256_20"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/14221.6244"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-39"},{"issue":"3","key":"e_1_3_6_27_1","first-page":"e459","article-title":"Stevens-Johnson Syndrome associated with methotrexate treatment for acute lymphoblastic leukemia: a case report","volume":"116","author":"Akinci B","year":"2018","unstructured":"Akinci B, Sivis ZO, Sahin A, et al. Stevens-Johnson Syndrome associated with methotrexate treatment for acute lymphoblastic leukemia: a case report. Arch Argent Pediatr. 2018 Jun;116(3):e459\u2013e462.","journal-title":"Arch Argent Pediatr"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70029-X"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2015.713"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01608.x"},{"key":"e_1_3_6_31_1","first-page":"101","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome in furosemide-treated patients: a study of the French Pharmacovigilance database","volume":"25","author":"Paret N","year":"2011","unstructured":"Paret N, Baldin B, Jonville-Bera A, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome in furosemide-treated patients: a study of the French Pharmacovigilance database. Fundam Clin Pharmacol. 2011 Apr;25:101.","journal-title":"Fundam Clin Pharmacol"},{"issue":"10","key":"e_1_3_6_32_1","first-page":"960","article-title":"furosemide-induced toxic epidermal necrolysis","volume":"32","author":"Mebazaa A","year":"2009","unstructured":"Mebazaa A, Moula H, Beji S, et al. furosemide-induced toxic epidermal necrolysis. Drug Saf. 2009;32(10):960\u2013961.","journal-title":"Drug Saf"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6024.1509"},{"issue":"12","key":"e_1_3_6_34_1","first-page":"Wd1","article-title":"Carvedilol induced toxic epidermal necrolysis: a rare case report","volume":"15","author":"Dhande R","year":"2021","unstructured":"Dhande R, Madke B, Singh A, et al. Carvedilol induced toxic epidermal necrolysis: a rare case report. J Clin Diagn Res. 2021 Dec;15(12):Wd1\u2013Wd2.","journal-title":"J Clin Diagn Res"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488612805076543"},{"issue":"7","key":"e_1_3_6_36_1","first-page":"548","article-title":"Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease","volume":"10","author":"Hani N","year":"2000","unstructured":"Hani N, Casper C, Groth W, et al. Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease. Eur J Dermatol. 2000 Oct;10(7):548\u2013550.","journal-title":"Eur J Dermatol"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00022-3.x"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2823"},{"issue":"6","key":"e_1_3_6_39_1","first-page":"694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann BC","year":"2006","unstructured":"Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncology. 2006 Jun;11(6):694\u2013703.","journal-title":"Oncology"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0772-0"},{"key":"e_1_3_6_41_1","first-page":"15","article-title":"Drug interactions with methotrexate","volume":"12","author":"Evans WE","year":"1985","unstructured":"Evans WE, Christensen ML. Drug interactions with methotrexate. J Rheumatol Suppl. 1985 Dec;12 Suppl 12:15\u201320.","journal-title":"J Rheumatol Suppl"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.6048"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2203482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T10:49:47Z","timestamp":1707734987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2203482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"alternative-id":["10.1080\/14740338.2023.2203482"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2203482","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}